SUVEN LIFE SCIENCES LIMITED

OVERVIEW

Suven Life Sciences Limited is a listed public company. It was incorporated on 09 March, 1989 and is located in Hyderabad, Telangana. It is classified as a public limited company.The company has eight directors - Gopala Krishna Muddusetty, Rangaswamy Naidu Maripuri, and others.

Description: It is a biopharmaceutical company, operates through manufacturing, services, research and development segments. It manufactures and sells bulk drugs through intermediaries.

Products & Services: Contract Research And Manufacturing Services (C.R.A.M.S)-Intermediates, Active Pharma Ingredients, / Drug Discovery & Development Support Services (DDDSS)- Synthetic and Medicinal Chemistry, Analytical Chemistry, In vitro Biology, ADME, Pharmacology, Toxicology, Bioanalysis, NCE Formulations, / Drug Discovery & Research/Clinical pipeline- SUVN-502, SUVN-G3031, SUVN-D4010, SUVN-911, SUVN-I6107
Category: Manufacturer & Service Provider

Suven Life Sciences Limited's operating revenues range is Over INR 500 cr for the financial year ending on 31 March, 2019. It's EBITDA has decreased by -3.29 % over the previous year. At the same time, it's book networth has increased by 14.64 %. Other performance and liquidity ratios are available here.

The registered office of the company is at DOOR No. 8-2-334, 6th FLOOR, SDE SERENE CHAMBERS ROAD No. 5, AVENUE 7, BANJARA HILLS, HYDERABAD, Hyderabad, Telangana.

The total paid-up capital is INR 12.73 cr. The last reported AGM (Annual General Meeting) of the company, per our records, was held on 14 August, 2019. Also, as per our records, its last balance sheet was prepared for the period ending on 31 March, 2019.

  • COMPANY FINANCIALS
  • INR 499/-
    All financials and shareholder returns filed with MCA since year 2006 upto 31 March, 2019 along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 349/-
    Balance Sheet, Profit and Loss# and shareholder return for last three years upto 31 March, 2019 along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 249/-
    Balance Sheet, Profit and Loss# and shareholder return for 31 March, 2019 along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 799/-
    An easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more.
    Delivery time: 1 working day (Mon-Fri).
    View a Sample Report
  • # Wherever available
    * Prices are exclusive of taxes.
    ** Company has reported to have approved financials for 31 March, 2019. However, in case, they are not yet filed with MCA, then last filed financials shall be provided instead.
    *** Working hours: 9am-6pm (Mon-Fri)

company 360 lite

360lite-screenshot

Get unlimited access to Tofler's entire database

@ INR 9000/quarter

learn more

REGISTERED DETAILS


CIN

L24110TG1989PLC009713

Incorporation Date / Age

09 March, 1989 / 31 yrs

Last Reported AGM Date

14 August, 2019


Authorized Capital

INR 4000.0 Lacs

Paidup Capital

INR 1272.82478 Lacs

industry*

Manufacturing (Chemicals and chemical products)


type

Listed Public Company

category

Company limited by Shares

subcategory

Non-govt company


Email Address

Login for email address. This is to prevent spam.

Website

http://www.suven.com/. (Incorrect website?)

Registered Address

DOOR No. 8-2-334, 6th FLOOR, SDE SERENE CHAMBERS
ROAD No. 5, AVENUE 7, BANJARA HILLS
HYDERABAD
Hyderabad - 500034
Telangana - India

SUVEN LIFE SCIENCES LIMITED - Registration Details
CINL24110TG1989PLC009713
Incorporation Date / Age09 March, 1989 / 31 yrs
Last Reported AGM Date14 August, 2019
Authorized CapitalINR 4000.0 Lacs
Paidup CapitalINR 1272.82478 Lacs
industry*Manufacturing (Chemicals and chemical products)
typeListed Public Company
categoryCompany limited by Shares
subcategoryNon-govt company
Email Address
Websitehttp://www.suven.com/
Registered AddressDOOR No. 8-2-334, 6th FLOOR, SDE SERENE CHAMBERS ROAD No. 5, AVENUE 7, BANJARA HILLS HYDERABAD Hyderabad - 500034 Telangana - India

FINANCIAL HIGHLIGHTS

Provided here are the financial indicators for financial year ending on 31 March, 2019. Actual numbers and more financial data, updated until 31 March, 2019* are included in purchased financial report.
View Sample Report.
Operating Revenue Over INR 500 cr
EBITDA -3.29 %
Networth 14.64 %
Debt/Equity Ratio 0.04
Return on Equity 15.10 %

* Company has reported to have approved financials for 31 March, 2019. However, in case, they are not yet filed with MCA, then last filed financials shall be provided instead.

Directors

The company has 8 directors and 3 reported key management personnel.


The longest serving director currently on board is Rangaswamy Naidu Maripuri who was appointed on 07 September, 1998. Rangaswamy Naidu Maripuri has been on the board for more than 21 years. The most recently appointed director is Ananthasai Padmaja Jasthi, who was appointed on 14 November, 2018.


Gopala Krishna Muddusetty has the largest number of other directorships with a seat at a total of 10 companies. In total, the company is connected to 32 other companies through its directors.


NAME DESIGNATION APPOINTMENT DATE
GOPALA KRISHNA MUDDUSETTY Director 14 November, 2012 Other directorships - BGR ENERGY SYSTEMS LIMITED,  NSL RENEWABLE POWER PRIVATE LIMITED,  OLECTRA GREENTECH LIMITED,  PITTI ENGINEERING LIMITED,  PRABHAT AGRI BIOTECH LIMITED,  AVRA SYNTHESIS PRIVATE LIMITED,  NSL TEXTILES LIMITED,  AVRA LABORATORIES PRIVATE LIMITED,  THE ANDHRA PETROCHEMICALS LIMITED, 
RANGASWAMY NAIDU MARIPURI Director 07 September, 1998 No other directorships
GOVINDA PRASAD DASU Director 19 January, 2009 Other directorships - GOKAK TEXTILES LIMITED,  SUVEN PHARMACEUTICALS LIMITED,  MOSCHIP TECHNOLOGIES LIMITED,  NATCO PHARMA LIMITED, 
SUDHARANI JASTI Director 04 January, 2013 Other directorships - JS PROPERTY HOLDINGS LLP,  DR. MJ PROPERTY HOLDINGS LLP,  SVJ PROPERTY HOLDINGS LLP,  KJ PROPERTY HOLDINGS LLP,  SVSMKS PROPERTY LLP,  TRIBUTE PHARMACEUTICALS PRIVATE LIMITED,  JASTI PROPERTY AND EQUITY HOLDINGS PRIVATE LIMITED, 
VENKATESWARLU JASTI Director 04 January, 2010 Other directorships - JS PROPERTY HOLDINGS LLP,  DR. MJ PROPERTY HOLDINGS LLP,  SVJ PROPERTY HOLDINGS LLP,  KJ PROPERTY HOLDINGS LLP,  SUVEN NISHTAA PHARMA PRIVATE LIMITED,  SUVEN PHARMACEUTICALS LIMITED,  TRIBUTE PHARMACEUTICALS PRIVATE LIMITED,  JASTI PROPERTY AND EQUITY HOLDINGS PRIVATE LIMITED,  THE FEDERATION OF TELANGANA CHAMBERS OF COMMERCE AND INDUSTRY, 
VENKATESWARLU JASTI CEO 01 November, 2014 No other directorships
SUBBA RAO PARUPALLY CFO 10 February, 2015 No other directorships
SEYED EHTESHAM HASNAIN Director 30 April, 2010 Other directorships - VALETUDE PRIMUS HEALTHCARE PRIVATE LIMITED,  YASHRAJ BIOTECHNOLOGY LIMITED,  DR.REDDY'S INSTITUTE OF LIFE SCIENCES,  IGNOVISION SOLUTIONS PRIVATE LIMITED, 
ANANTHASAI PADMAJA JASTHI Director 14 November, 2018 No other directorships
SANTANU MUKHERJEE Director 15 May, 2018 Other directorships - AERIES FINANCIALTECHNOLOGIES PRIVATE LIMITED,  DONEAR INDUSTRIES LIMITED,  MUTHOOT HOUSING FINANCE COMPANY LIMITED,  SUMEDHA FISCAL SERVICES LTD,  VISHNU BARIUM PRIVATE LIMITED,  BANDHAN BANK LIMITED, 
HANUMANTHA RAO KOKKONDA Secretary 06 December, 2000 No other directorships
NAME DESIGNATION APPOINTMENT DATE
GOPALA KRISHNA MUDDUSETTY Director 14 November, 2012 View other directorships
RANGASWAMY NAIDU MARIPURI Director 07 September, 1998 No other directorships
GOVINDA PRASAD DASU Director 19 January, 2009 View other directorships
SUDHARANI JASTI Director 04 January, 2013 View other directorships
VENKATESWARLU JASTI Director 04 January, 2010 View other directorships
VENKATESWARLU JASTI CEO 01 November, 2014 No other directorships
SUBBA RAO PARUPALLY CFO 10 February, 2015 No other directorships
SEYED EHTESHAM HASNAIN Director 30 April, 2010 View other directorships
ANANTHASAI PADMAJA JASTHI Director 14 November, 2018 No other directorships
SANTANU MUKHERJEE Director 15 May, 2018 View other directorships
HANUMANTHA RAO KOKKONDA Secretary 06 December, 2000 No other directorships
07 September, 1998
06 December, 2000

HANUMANTHA RAO KOKKONDA

Secretary

19 January, 2009
04 January, 2010
30 April, 2010
14 November, 2012
04 January, 2013

SUDHARANI JASTI

Director

01 November, 2014

VENKATESWARLU JASTI

CEO

10 February, 2015

SUBBA RAO PARUPALLY

CFO

15 May, 2018
14 November, 2018

Bank-wise Biggest Charges on Assets

See more...

Previous Names

SUVEN PHARMACEUTICALS LTD

Previous CINs

No previous CINs were found for this company.

SIMILAR COMPANIES

NAME INCORPORATION YEAR STATE PAID UP CAPITAL
1985 Maharashtra 12.73 cr Buy financial reports
1995 Karnataka 12.68 cr Buy financial reports
1999 Andhra Pradesh 12.66 cr Buy financial reports
2005 Rajasthan 12.65 cr Buy financial reports
1997 Telangana 12.93 cr Buy financial reports
1992 West Bengal 12.53 cr Buy financial reports
1984 Telangana 12.94 cr Buy financial reports
2011 Chandigarh 12.51 cr Buy financial reports
2014 Andhra Pradesh 12.95 cr Buy financial reports
1975 Maharashtra 12.50 cr Buy financial reports

Company Network

Company Network • Tofler Business Research Platform

ABOUT COMPANY

Overview Add

* Square image works best

* Crop your image before you upload

* Image size should be less than 2MB

* Accepted image types: JPG, JPEG and PNG

Also known as:

Website:

Description:

Categories:

Industry:

Products & services:

Product brand:

* Square image works best

* Crop your image before you upload

* Image size should be less than 2MB

* Accepted image types: JPG, JPEG and PNG

Also known as:

Website: http://www.suven.com/

Description: It is a biopharmaceutical company, operates through manufacturing, services, research and development segments. It manufactures and sells bulk drugs through intermediaries.

Categories:

Industry:

Products & services: Contract Research And Manufacturing Services (C.R.A.M.S)-Intermediates, Active Pharma Ingredients, / Drug Discovery & Development Support Services (DDDSS)- Synthetic and Medicinal Chemistry, Analytical Chemistry, In vitro Biology, ADME, Pharmacology, Toxicology, Bioanalysis, NCE Formulations, / Drug Discovery & Research/Clinical pipeline- SUVN-502, SUVN-G3031, SUVN-D4010, SUVN-911, SUVN-I6107

Product brand:

People Add

No. of employee:

Chairman:

Ceo:

Managing director:

Founder:+ADD

No. of employees:

Chairman:

Ceo:

Managing director:

Founder:+ADD

Contact Add

Corporate address:

Contact email:

Facebook:

LinkedIn:

Twitter:

Corporate address:

Contact email:

Facebook:

LinkedIn: 

Twitter:   

  • COMPANY FINANCIALS
  • INR 499/-
    All financials and shareholder returns filed with MCA since year 2006 upto 31 March, 2019 along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 349/-
    Balance Sheet, Profit and Loss# and shareholder return for last three years upto 31 March, 2019 along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 249/-
    Balance Sheet, Profit and Loss# and shareholder return for 31 March, 2019 along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 799/-
    An easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more.
    Delivery time: 1 working day (Mon-Fri).
    View a Sample Report
  • # Wherever available
    * Prices are exclusive of taxes.
    ** Company has reported to have approved financials for 31 March, 2019. However, in case, they are not yet filed with MCA, then last filed financials shall be provided instead.
    *** Working hours: 9am-6pm (Mon-Fri)

company 360 lite

360lite-screenshot

Get unlimited access to Tofler's entire database

@ INR 9000/quarter

learn more



Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to their respective owners. Read More